Papers

8

Total Citations

100

H-Index

5

About

Lijian Gan is a leading voice in the comparative effectiveness of robotic versus laparoscopic urologic surgery. His research systematically evaluates how robotic assistance improves outcomes across adrenal, testicular, bladder, and upper-tract urothelial cancers. His most cited work, a 2022 meta-analysis on adrenalectomy (49 citations), established key safety and efficacy benchmarks for robotic-assisted procedures. Gan’s 2023 meta-analysis on robotic retroperitoneal lymph node dissection for testicular cancer (12 citations) and his 2024 study on single-port versus multi-port robotic techniques (12 citations) demonstrate his commitment to refining minimally invasive approaches. He has also advanced pediatric urology with a meta-analysis comparing external and DJ stents for pyeloplasty (5 citations). Collectively, his meta-analyses—spanning adrenalectomy, cystectomy, nephroureterectomy, and inguinal lymph node dissection—provide high-level evidence guiding surgical decision-making. Gan’s work is essential reading for urologists and researchers seeking data-driven comparisons of robotic and laparoscopic techniques, with his cumulative findings shaping modern urologic practice.

Research Focus

Key Achievements

5
H-Index
8
Papers
100
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of the effectiveness and safety of robotic-assisted and laparoscopic in adrenalectomy: A systematic review and meta-analysis
49 citations · 2022
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: North Sichuan Medical University, Beijing Chaoyang Emergency Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago